Biosimilar Newsletter Archive
-
11.06.23 -- Design A Successful Viral Clearance Study For Your Biologic
11/6/2023
11/06/23 Biosimilar Development Newsletter
-
11.02.23 -- FDA Updates Labeling Recommendations For Biosimilar Products
11/2/2023
11/02/23 Biosimilar Development Newsletter
-
10.26.23 -- 5 Best Practices For Responding To FDA Form 483 Inspection Observations
10/26/2023
10/26/23 Biosimilar Development Newsletter
-
10.25.23 -- Key Considerations For Aseptic Filling
10/25/2023
10/25/23 Biosimilar Development Newsletter
-
10.19.23 -- FDA Grants Interchangeable Designation To Pfizer's Biosimilar ABRILADA
10/19/2023
10/19/23 Biosimilar Development Newsletter
-
10.12.23 -- The Cancer Drug Shortage: When Quality Fails
10/12/2023
10/12/23 Biosimilar Development Newsletter
-
10.11.23 -- Find A Data-Driven Approach To Container Closure Integrity
10/11/2023
10/11/23 Biosimilar Development Newsletter
-
10.05.23 -- Get The Most From Your Cell Culture
10/5/2023
10/05/23 Biosimilar Development Newsletter
-
10.05.23 -- Key Post-Pandemic Trends In Global FDA Observations For Drug Facilities
10/5/2023
10/05/23 Biosimilar Development Newsletter
-
10.02.23 -- Securing Your Consumables Supply Chain
10/2/2023
10/02/23 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more